COOPERATION AGREEMENTCooperation Agreement • July 1st, 2024 • Lifecore Biomedical, Inc. \De\ • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 1st, 2024 Company Industry JurisdictionThis Cooperation Agreement (this “Agreement”) is made and entered into as of June 28, 2024 (the “Effective Date”) by and among Lifecore Biomedical, Inc., a Delaware corporation (“Lifecore” or the “Company”), and each of the persons listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors” or the “Investor Group”). The Company and each of the Investors are each herein referred to as a “party” and collectively, the “parties”. Unless otherwise defined herein, capitalized terms shall have the meanings given to them in Section 13 herein.
COOPERATION AGREEMENTCooperation Agreement • July 1st, 2024 • Lifecore Biomedical, Inc. \De\ • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 1st, 2024 Company Industry JurisdictionThis Cooperation Agreement (this “Agreement”) is made and entered into as of June 28, 2024 (the “Effective Date”) by and among Lifecore Biomedical, Inc., a Delaware corporation (“Lifecore” or the “Company”), and each of the persons listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors” or the “Investor Group”). The Company and each of the Investors are each herein referred to as a “party” and collectively, the “parties”. Unless otherwise defined herein, capitalized terms shall have the meanings given to them in Section 13 herein.